Maxcyte (MXCT) Return on Capital Employed Growth (1y) (2022 - 2026)
Maxcyte (MXCT) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 216.00 |
| 10 | Maxcyte | 148.48 Mn | 148.48 Mn | 5.60 Mn | 181.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 181.00 |
| Mar 31, 2026 | -125.00 |
| Dec 31, 2025 | -436.00 |
| Sep 30, 2025 | -676.00 |
| Jun 30, 2025 | -598.00 |
| Mar 31, 2025 | -409.00 |
| Dec 31, 2024 | -308.00 |
| Sep 30, 2024 | -135.00 |
| Jun 30, 2024 | -362.00 |
| Mar 31, 2024 | -538.00 |
| Dec 31, 2023 | -925.00 |
| Sep 30, 2023 | -919.00 |
| Jun 30, 2023 | -802.00 |
| Mar 31, 2023 | -773.00 |
| Dec 31, 2022 | -324.00 |
| Sep 30, 2022 | -39.00 |